The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 22, 2016

Filed:

Mar. 05, 2013
Applicant:

The University of Montana, Missoula, MT (US);

Inventors:

John M. Gerdes, Coos Bay, OR (US);

Richard J. Bridges, Missoula, MT (US);

Syed K. Ahmed, Hyderabad, IN;

Sarjubhai Patel, Missoula, MT (US);

Assignee:

THE UNIVERSITY OF MONTANA, Missoula, MT (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); C07C 69/635 (2006.01); C07C 237/04 (2006.01); C07B 59/00 (2006.01); A61K 51/04 (2006.01); C07C 67/317 (2006.01); C07F 7/22 (2006.01);
U.S. Cl.
CPC ...
C07C 69/635 (2013.01); A61K 51/04 (2013.01); C07B 59/001 (2013.01); C07C 67/317 (2013.01); C07C 237/04 (2013.01); C07F 7/2212 (2013.01); C07B 2200/05 (2013.01); C07C 2103/18 (2013.01);
Abstract

The compounds of the invention are inhibitors of excitatory amino acid transporters (EAAT) that penetrate the blood-brain barrier to access the central nervous system. The compounds of the invention follow the structural formula: or a salt, ester or prodrug thereof, wherein X is a halogen, such as fluorine, or a radionuclide, such as fluorine-18. The compounds and methods described herein can be used for the treatment of, e.g., neurodegenerative disorders (e.g., amyotrophic lateral sclerosis), ischemia, spinal cord injury, and traumatic brain injury in a patient (e.g., a human). The invention further provides compounds and methods for the synthesis and use of radiographic tracers to diagnose and follow the progression of such disorders.


Find Patent Forward Citations

Loading…